Literature DB >> 27323227

In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.

Demidmaa Tuvdendorj1, Alejandro O Munoz2, Viviana Ruiz-Barros3, Jean-Marc Schwarz3, Giuseppe Montalto4, Manisha Chandalia2, Lawrence C Sowers5, Manfredi Rizzo6, Elizabeth J Murphy3, Nicola Abate2.   

Abstract

BACKGROUNDS AND AIMS: Low concentrations of plasma HDL-C are associated with the development of atherosclerotic cardiovascular diseases and type 2 diabetes. Here we aimed to explore the relationship between the in vivo fractional synthesis of triglycerides (fTG) in subcutaneous (s.q.) abdominal adipose tissue (AT), HDL-C concentrations and HDL particle size composition in non-diabetic humans.
METHODS: The fTG in s.q. abdominal AT was measured in 16 non-diabetic volunteers (7 women, 9 men; Age: 49 ± 20 years; BMI: 31 ± 5 kg/m; Fasting Plasma Glucose: 90 ± 10 mg/dl) after (2)H2O labeling. HDL-C concentration and subclasses, large (L-HDL), intermediate (I-HDL) and small (S-HDL) were measured.
RESULTS: Linear regression analyses demonstrated significant associations of fTG with plasma concentration of HDL-C (r = 0.625,p = 0.009) and percent contribution of L-HDL (r = 0.798,p < 0.001), I-HDL (r = -0.765,p < 0.001) and S-HDL (r = -0.629, p = 0.009). When analyses were performed by gender, the associations remained significant in women (HDL-C: r = 0.822,p = 0.023; L-HDL: r = 0.892,p = 0.007; I-HDL: r = -0.927,p = 0.003) but not men.
CONCLUSIONS: Our study demonstrated an in vivo association between subcutaneous abdominal adipose tissue lipid dynamics and HDL parameters in humans, but this was true for women not men. Positive association with L-HDL and negative with I-HDL suggest that subcutaneous abdominal adipose tissue lipid dynamics may play an important role in production of mature functional HDL particles. Further studies evaluating the mechanism responsible for these associations and the observed gender differences are important and warranted to identify potential novel targets of intervention to increase the production of atheroprotective subclasses of HDL-Cs and thus decreasing the risks of development of atherosclerotic conditions.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adipocyte; Atheroprotective; Gender-related; HDL-C metabolism; Mass spectrometry; Stable isotope tracer kinetics; Triglycerides

Mesh:

Substances:

Year:  2016        PMID: 27323227      PMCID: PMC4983221          DOI: 10.1016/j.atherosclerosis.2016.06.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  46 in total

Review 1.  Differential diagnosis of familial high density lipoprotein deficiency syndromes.

Authors:  Arnold von Eckardstein
Journal:  Atherosclerosis       Date:  2005-12-15       Impact factor: 5.162

Review 2.  Subfractions and subpopulations of HDL: an update.

Authors:  M Rizzo; J Otvos; D Nikolic; G Montalto; P P Toth; M Banach
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 3.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

4.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus.

Authors:  D E Kelley; K V Williams; J C Price; T M McKolanis; B H Goodpaster; F L Thaete
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 6.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

Review 7.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

Authors:  Sam Virtue; Antonio Vidal-Puig
Journal:  Biochim Biophys Acta       Date:  2010-01-06

8.  Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study.

Authors:  C M Burchfiel; R F Hamman; J A Marshall; J Baxter; L B Kahn; J J Amirani
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

Review 9.  Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus.

Authors:  Eric Ravussin; Steven R Smith
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Lipid-related markers and cardiovascular disease prediction.

Authors:  Emanuele Di Angelantonio; Pei Gao; Lisa Pennells; Stephen Kaptoge; Muriel Caslake; Alexander Thompson; Adam S Butterworth; Nadeem Sarwar; David Wormser; Danish Saleheen; Christie M Ballantyne; Bruce M Psaty; Johan Sundström; Paul M Ridker; Dorothea Nagel; Richard F Gillum; Ian Ford; Pierre Ducimetiere; Stefan Kiechl; Wolfgang Koenig; Robin P F Dullaart; Gerd Assmann; Ralph B D'Agostino; Gilles R Dagenais; Jackie A Cooper; Daan Kromhout; Altan Onat; Robert W Tipping; Agustín Gómez-de-la-Cámara; Annika Rosengren; Susan E Sutherland; John Gallacher; F Gerry R Fowkes; Edoardo Casiglia; Albert Hofman; Veikko Salomaa; Elizabeth Barrett-Connor; Robert Clarke; Eric Brunner; J Wouter Jukema; Leon A Simons; Manjinder Sandhu; Nicholas J Wareham; Kay-Tee Khaw; Jussi Kauhanen; Jukka T Salonen; William J Howard; Børge G Nordestgaard; Angela M Wood; Simon G Thompson; S Matthijs Boekholdt; Naveed Sattar; Chris Packard; Vilmundur Gudnason; John Danesh
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  3 in total

1.  Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans.

Authors:  Fatima Iqbal; William J Durham; Ayyash Melhem; Saleem Raslan; Tony T Tran; Traver J Wright; Rabia Asghar; Ken Fujise; Elena Volpi; Labros Sidossis; Nicola Abate; Melinda Sheffield-Moore; Demidmaa Tuvdendorj
Journal:  Int J Dev Neurosci       Date:  2017-07-12       Impact factor: 2.457

2.  Racial differences in in vivo adipose lipid kinetics in humans.

Authors:  Ursula A White; Mark D Fitch; Robbie A Beyl; Marc K Hellerstein; Eric Ravussin
Journal:  J Lipid Res       Date:  2018-06-17       Impact factor: 5.922

Review 3.  Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors:  Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.